glur5 receptor

Topiramate D12 is a deuterium labeled Topiramate. Topiramate is an agent of broad-spectrum antiepileptic. Topiramate is an antagonist of GluR5 receptor.

LY339434 HCl是一种亲和力很低的GluR5红氨酸受体激动剂。LY339434 HCl 主要通过影响 N-甲基-D-天冬氨酸（NMDA）受体来快速的神经元死亡。

LY382884 是一种具有选择性和有效性的 GLU(K5)受体拮抗剂，具有抗焦虑活性。LY382884可阻断阻断苔藓纤维LTP的诱导。

ATPA is a selective glutamate receptor GluR5 activator (EC50s: 0.66, 1.4, 9.5, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S721T), GluR5(S741M), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V)).

GluR5-containing kainate receptor antagonist

GluR5-subunit containing kainate receptor antagonist

UBP310 (UBP 310) 是选择性GluR5拮抗剂，Kd 值为 130 nM。

LY339434 is a potent and selective agonist of the kainate receptor GluK1, GluR5.

Topiramate lithium (McN 4853) is a wide-ranging antiepileptic compound with GluR5 receptor antagonistic properties. Its mechanism of action involves enhancing GABAergic activity, inhibiting kainate AMPA receptors, voltage-sensitive sodium and calcium channels, and increasing potassium conductance. Additionally, this compound inhibits carbonic anhydrase. [1][2][3]